A toll-like receptor-responsive kinase, Protein Kinase R, is inactivated in endotoxin tolerance through differential K63/K48 ubiquitination

mBio

Volumn 1, Issue 5, 2010, Pages

  Perkins, Darren J ^a   Qureshi, Nilofer ^b   Vogel, Stefanie N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; LYSINE; PROTEIN KINASE R;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; UBIQUITINATION;

ANIMALS; CELLS, CULTURED; EIF-2 KINASE; ENDOTOXINS; HUMANS; IMMUNE TOLERANCE; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; TOLL-LIKE RECEPTOR 4; UBIQUITINATION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 79952165858     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00239-10     Document Type: Article

References (44)

1. Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature 454:428-435.
2. Remick, D. G. 2003. Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr. Pharm. Des. 9:75-82.
3. West, M. A., and W. Heagy. 2002. Endotoxin tolerance: a review. Crit. Care Med. 30:S64-S73.
4. Docke, W. D., F. Randow, U. Syrbe, D. Krausch, K. Asadullah, P. Reinke, H. D. Volk, and W. Kox. 1997. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3:678-681.
5. Munoz, C., J. Carlet, C. Fitting, B. Misset, J. P. Bleriot, and J. M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88:1747-1754.
6. Flach, R., M. Majetschak, T. Heukamp, V. Jennissen, S. Flohe, J. Borgermann, U. Obertacke, and F. U. Schade. 1999. Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 11:173-178.
7. Shahbazian, L. M., M. Jeevanandam, and S. R. Petersen. 1999. Release of proinflammatory cytokines by mitogen-stimulated peripheral blood mononuclear cells from critically ill multiple-trauma victims. Metabolism 48:1397-1401.
8. Medvedev, A. E., I. Sabroe, J. D. Hasday, and S. N. Vogel. 2006. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J. Endotoxin Res. 12:133-150.
9. Rittirsch, D., M. A. Flierl, and P. A. Ward. 2008. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8:776-787.
10. Henricson, B. E., C. L. Manthey, P. Y. Perera, T. A. Hamilton, and S. N. Vogel. 1993. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect. Immun. 61:2325-2333.
11. Shnyra, A., R. Brewington, A. Alipio, C. Amura, and D. C. Morrison. 1998. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J. Immunol. 160:3729-3736.
12. Hirohashi, N., and D. C. Morrison. 1996. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect. Immun. 64:1011-1015.
13. Medvedev, A. E., A. Lentschat, L. M. Wahl, D. T. Golenbock, and S. N. Vogel. 2002. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169:5209-5216.
14. Medvedev, A. E., W. Piao, J. Shoenfelt, S. H. Rhee, H. Chen, S. Basu, L. M. Wahl, M. J. Fenton, and S. N. Vogel. 2007. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J. Biol. Chem. 282:16042-16053.
15. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191-202.
16. van 't Veer, C., P. S. van den Pangaart, M. A. van Zoelen, M. de Kruif, R. S. Birjmohun, E. S. Stroes, A. F. de Vos, and T. van der Poll. 2007. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179:7110-7120.
17. Li, L., S. Cousart, J. Hu, and C. E. McCall. 2000. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxintolerant cells. J. Biol. Chem. 275:23340-23345.
18. Yamin, T. T., and D. K. Miller. 1997. The interleukin-1 receptorassociated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272:21540-21547.
19. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447:972-978.
20. Nakagawa, R., T. Naka, H. Tsutsui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, S. Akira, K. Yamanishi, I. Kawase, K. Nakanishi, and T. Kishimoto. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677-687.
21. Cole, J. L. 2007. Activation of PKR: an open and shut case? Trends Biochem. Sci. 32:57-62.
22. Gale, M., Jr., S. L. Tan, and M. G. Katze. 2000. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64:239-280.
23. Sadler, A. J., and B. R. Williams. 2007. Structure and function of the protein kinase R. Curr. Top. Microbiol. Immunol. 316:253-292.
24. Horng, T., G. M. Barton, and R. Medzhitov. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:835-841.
25. Goh, K. C., M. J. deVeer, and B. R. Williams. 2000. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 19:4292-4297.
26. Hsu, L. C., J. M. Park, K. Zhang, J. L. Luo, S. Maeda, R. J. Kaufman, L. Eckmann, D. G. Guiney, and M. Karin. 2004. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428:341-345.
27. Bhoj, V. G., and Z. J. Chen. 2009. Ubiquitylation in innate and adaptive immunity. Nature 458:430-437.
28. Chen, Z. J., and L. J. Sun. 2009. Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 33:275-286.
29. Moynagh, P. N. 2009. The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling. Trends Immunol. 30:33-42.
30. Pineda, G., C. K. Ea, and Z. J. Chen. 2007. Ubiquitination and TRAF signaling. Adv. Exp. Med. Biol. 597:80-92.
31. Mansell, A., R. Smith, S. L. Doyle, P. Gray, J. E. Fenner, P. J. Crack, S. E. Nicholson, D. J. Hilton, L. A. O'Neill, and P. J. Hertzog. 2006. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7:148-155.
32. Lam, Y. A., W. Xu, G. N. DeMartino, and R. E. Cohen. 1997. Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 385:737-740.
33. Newton, K., M. L. Matsumoto, I. E. Wertz, D. S. Kirkpatrick, J. R. Lill, J. Tan, D. Dugger, N. Gordon, S. S. Sidhu, F. A. Fellouse, L. Komuves, D. M. French, R. E. Ferrando, C. Lam, D. Compaan, C. Yu, I. Bosanac, S. G. Hymowitz, R. F. Kelley, and V. M. Dixit. 2008. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 134:668-678.
34. Sato, S., O. Takeuchi, T. Fujita, H. Tomizawa, K. Takeda, and S. Akira. 2002. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int. Immunol. 14:783-791.
35. O'Neill, L. A. 2009. Regulation of signaling by non-degradative ubiquitination. J. Biol. Chem. 284:8209.
36. Wysocka, J., P. T. Reilly, and W. Herr. 2001. Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol. Cell. Biol. 21:3820-3829.
37. O'Shea, J. J., and P. J. Murray. 2008. Cytokine signaling modules in inflammatory responses. Immunity 28:477-487.
38. Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583-591.
39. Gingras, S., E. Parganas, A. de Pauw, J. N. Ihle, and P. J. Murray. 2004. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of Toll-like receptor signaling. J. Biol. Chem. 279:54702-54707.
40. Kim, Y. G., J. H. Park, M. H. Shaw, L. Franchi, N. Inohara, and G. Nunez. 2008. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28:246-257.
41. Bennett, R. L., W. L. Blalock, D. M. Abtahi, Y. Pan, S. A. Moyer, and W. S. May. 2006. RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. Blood 108:821-829.
42. Patel, R. C., and G. C. Sen. 1998. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17:4379-4390.
43. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6:2363-2372.
44. Vong, Q. P., K. Cao, H. Y. Li, P. A. Iglesias, and Y. Zheng. 2005. Chromosome alignment and segregation regulated by ubiquitination of survivin. Science 310:1499-1504.